Abstract

INVASIVE PULMONARY ASPERGILLOSIS (IPA) IN RELATION WITH COVID-19: A REVIEW

Akshay Eknath Bhujbal*, Deepak Kakasaheb Pisote, Snehal S. Shingne, Proff. Santosh Waghmare and Dr. H. V. Kamble

.

Abstract

Invasive Pulmonary Aspergillosis (IPA) is the infection in humans caused due to the 20 species of Aspergillus out of 200 species. In that the majorly infectious species are Aspergillus flavus, A. fumigatus, A. niger and A. terreus. In COVID-19 the patients are suffering from the IPA those are having the allergic reaction (asthma), airway disease (cystic fibrosis) or immune deficiency patients. In COVID-19 the use of corticosteroids is high that’s why the patients are get immunocompromised and they are having the chances to get infected by the IPA. The patients having the IPA found in COVID-19 as an asymptomatic, mild, moderate, severe and critical infection of COVID- 19. In this review we studied some reports and taken the information from the various literature. The purpose of this review to provide brief information on the Introduction, Pathophysiology, who at risk, Symptoms, Treatment for Invasive Pulmonary Aspergillosis related to the COVID-19.

Keywords: Invasive Pulmonary Aspergillosis, COVID-19, Aspergillus fumigatus.